Article Details
Retrieved on: 2020-11-22 22:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Sydney, 23 November 2020 - Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused <b>biotechnology</b> company, ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here